222
views
views
Gene Synthesis Market
Since the invention of gene synthesis, biosecurity concerns have followed. It can be misused to create pathogens and evade regulation. While some progress has been made in biosecurity protection, new advances in gene synthesis have significantly reduced the efficacy of biosecurity measures. For instance, in December 2021, Codex DNA, Inc., a biotech firm focused on gene synthesis in the U.S., released a full-length synthetic genome of the SARS-CoV-2 virus for its highly-contagious Omicron variant.
Read More:
Click here for Gene Synthesis Market Report:
https://www.coherentmarketinsights.com/market-insight/gene-synthesis-market-1533